Yoshida, K. et al. Frequent pathway mutations of splicing machinery in myelodysplasia. Nature 478, 64–69 (2011).
Google Scholar
Papaemmanuil, E. et al. Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts. New Engl. J. Med. 365, 1384–1395 (2011).
Google Scholar
Quesada, V. et al. Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia. Nat. Genet. https://doi.org/10.1038/ng.1032 (2011).
Graubert, T. A. et al. Recurrent mutations in the U2AF1 splicing factor in myelodysplastic syndromes. Nat. Genet. https://doi.org/10.1038/ng.1031 (2011).
Dvinge, H., Kim, E., Abdel-Wahab, O. & Bradley, R. K. RNA splicing factors as oncoproteins and tumour suppressors. Nat. Rev. Cancer 16, 413–430 (2016).
Google Scholar
Wang, L. et al. SF3B1 and other novel cancer genes in chronic lymphocytic leukemia. New Engl. J. Med. 365, 2497–2506 (2011).
Google Scholar
Harbour, J. W. et al. Recurrent mutations at codon 625 of the splicing factor SF3B1 in uveal melanoma. Nat. Genet. https://doi.org/10.1038/ng.2523 (2013).
Martin, M. et al. Exome sequencing identifies recurrent somatic mutations in EIF1AX and SF3B1 in uveal melanoma with disomy 3. Nat. Genet. https://doi.org/10.1038/ng.2674 (2013).
Furney, S. J. et al. SF3B1 mutations are associated with alternative splicing in uveal melanoma. Cancer Disc. https://doi.org/10.1158/2159-8290.cd-13-0330 (2013).
Alsafadi, S. et al. Cancer-associated SF3B1 mutations affect alternative splicing by promoting alternative branchpoint usage. Nat. Commun. 7, 10615 (2016).
Google Scholar
Yoshimi, A. et al. Coordinated alterations in RNA splicing and epigenetic regulation drive leukaemogenesis. Nature 574, 273–277 (2019).
Google Scholar
The Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature https://doi.org/10.1038/nature11412 (2012).
Mian, S. A. et al. SF3B1 mutant MDS-initiating cells may arise from the haematopoietic stem cell compartment. Nat. Commun. 6, 10004 (2015).
Google Scholar
Lee, S. C.-W. et al. Modulation of splicing catalysis for therapeutic targeting of leukemia with mutations in genes encoding spliceosomal proteins. Nat. Med. https://doi.org/10.1038/nm.4097 (2016).
Obeng, E. A. et al. Physiologic expression of Sf3b1(K700E) causes impaired erythropoiesis, aberrant splicing, and sensitivity to therapeutic spliceosome modulation. Cancer Cell 30, 404–417 (2016).
Google Scholar
Shirai, C. L. et al. Mutant U2AF1-expressing cells are sensitive to pharmacological modulation of the spliceosome. Nat. Commun. 8, 14060 (2017).
Google Scholar
Wang, E. et al. Targeting an RNA-binding protein network in acute myeloid leukemia. Cancer Cell 35, 369–384.e7 (2019).
Google Scholar
DeBoever, C. et al. Transcriptome sequencing reveals potential mechanism of cryptic 3′ splice site selection in SF3B1-mutated cancers. PLoS Comput. Biol. 11, e1004105 (2015).
Google Scholar
Kim, E. et al. SRSF2 mutations contribute to myelodysplasia by mutant-specific effects on exon recognition. Cancer Cell 27, 617–630 (2015).
Google Scholar
Ilagan, J. O. et al. U2AF1 mutations alter splice site recognition in hematological malignancies. Genome Res. 25, 14–26 (2015).
Google Scholar
Brooks, A. N. et al. A pan-cancer analysis of transcriptome changes associated with somatic mutations in U2AF1 reveals commonly altered splicing events. PLoS ONE 9, e87361 (2014).
Google Scholar
Darman, R. B. et al. Cancer-associated SF3B1 hotspot mutations induce cryptic 3? Splice site selection through use of a different branch point. Cell Rep. 13, 1033–1045 (2015).
Google Scholar
Zhang, J. et al. Disease-associated mutation in SRSF2 misregulates splicing by altering RNA-binding affinities. Proc. Natl Acad. Sci. USA https://doi.org/10.1073/pnas.1514105112 (2015).
Inoue, D. et al. Spliceosomal disruption of the non-canonical BAF complex in cancer. Nature 574, 432–436 (2019).
Yeo, G. & Burge, C. B. Maximum entropy modeling of short sequence motifs with applications to RNA splicing signals. J. Comput. Biol. 11, 377–394 (2004).
Google Scholar
Gozani, O., Potashkin, J. & Reed, R. A potential role for U2AF-SAP 155 interactions in recruiting U2 snRNP to the branch site. Mol. Cell. Biol. 18, 4752–4760 (1998).
Google Scholar
Spies, N., Nielsen, C. B., Padgett, R. A. & Burge, C. B. Biased chromatin signatures around polyadenylation sites and exons. Mol. Cell 36, 245–254 (2009).
Google Scholar
Smith, K. O., Galloway, K. S., Kennell, W. L., Ogilvie, K. K. & Radatus, B. K. A new nucleoside analog, 9-[[2-hydroxy-1-(hydroxymethyl)ethoxyl]methyl]guanine, highly active in vitro against herpes simplex virus types 1 and 2. Antimicrob. Agents 22, 55–61 (1982).
Google Scholar
Rosenberg, A. B., Patwardhan, R. P., Shendure, J. & Seelig, G. Learning the sequence determinants of alternative splicing from millions of random sequences. Cell 163, 698–711 (2015).
Google Scholar
Wong, M. S., Kinney, J. B. & Krainer, A. R. Quantitative activity profile and context dependence of all human 5′ splice sites. Mol. Cell https://doi.org/10.1016/j.molcel.2018.07.033 (2018).
Liu, B. et al. Mutant SF3B1 promotes AKT and NF-kB driven mammary tumorigenesis. J. Clin. Invest. https://doi.org/10.1172/jci138315 (2020).
Dorer, D. E. & Nettelbeck, D. M. Targeting cancer by transcriptional control in cancer gene therapy and viral oncolysis. Adv Drug Deliver. Rev. 61, 554–571 (2009).
Google Scholar
Lienert, F., Lohmueller, J. J., Garg, A. & Silver, P. A. Synthetic biology in mammalian cells: next generation research tools and therapeutics. Nat. Rev. Mol. Cell Bio. 15, 95–107 (2014).
Google Scholar
Wu, M.-R., Jusiak, B. & Lu, T. K. Engineering advanced cancer therapies with synthetic biology. Nat. Rev. Cancer 19, 187–195 (2019).
Google Scholar
Culler, S. J., Hoff, K. G. & Smolke, C. D. Reprogramming cellular behavior with RNA controllers responsive to endogenous proteins. Science 330, 1251–1255 (2010).
Google Scholar
Watanabe, T. & Sullenger, B. A. Induction of wild-type p53 activity in human cancer cells by ribozymes that repair mutant p53 transcripts. Proc. Natl Acad. Sci. USA 97, 8490–8494 (2000).
Google Scholar
Hong, S.-H. et al. In vivo reprogramming of hTERT by trans-splicing ribozyme to target tumor cells. Mol. Ther. 16, 74–80 (2008).
Google Scholar
Kim, J. et al. Targeted regression of hepatocellular carcinoma by cancer-specific RNA replacement through microRNA regulation. Sci. Rep. 5, 12315 (2015).
Google Scholar
Lee, S.-J. et al. Phase I trial of intravenous Ad5CRT in patients with liver metastasis of gastrointestinal cancers. Cancer Gene Ther. 26, 174–178 (2019).
Google Scholar
Chung, H. K. et al. A compact synthetic pathway rewires cancer signaling to therapeutic effector release. Science 364, eaat6982 (2019).
Nissim, L. et al. Synthetic RNA-based immunomodulatory gene circuits for cancer immunotherapy. Cell 171, 1138–1150.e15 (2017).
Google Scholar
Dolatshad, H. et al. Disruption of SF3B1 results in deregulated expression and splicing of key genes and pathways in myelodysplastic syndrome hematopoietic stem and progenitor cells. Leukemia https://doi.org/10.1038/leu.2014.331 (2014).
Tyner, J. W. et al. Functional genomic landscape of acute myeloid leukaemia. Nature 60, 277–531 (2018).
Pangallo, J. et al. Rare and private spliceosomal gene mutations drive partial, complete, and dual phenocopies of hotspot alterations. Blood https://doi.org/10.1182/blood.2019002894 (2020).
Lee, S. C.-W. et al. Synthetic lethal and convergent biological effects of cancer-associated spliceosomal gene mutations. Cancer Cell 34, 225–241.e8 (2018).
Google Scholar
Griewank, K. G. et al. Genetic and molecular characterization of uveal melanoma cell lines. Pigment Cell Melanoma Res. 25, 182–187 (2012).
Google Scholar
Pineda, J. M. B. & Bradley, R. K. Most human introns are recognized via multiple and tissue-specific branchpoints. Genes Dev. 32, 577–591 (2018).
Google Scholar
Thomas, J. D. et al. RNA isoform screens uncover the essentiality and tumor-suppressor activity of ultraconserved poison exons. Nat. Genet. 52, 84–94 (2020).
Google Scholar
Martin, M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet J. 17, 10–12 (2011).
Magoč, T. & Salzberg, S. L. FLASH: fast length adjustment of short reads to improve genome assemblies. Bioinformatics 27, 2957–2963 (2011).
Google Scholar
Langmead, B. & Salzberg, S. L. Fast gapped-read alignment with Bowtie 2. Nat. Methods 9, 357–359 (2012).
Google Scholar
Flicek, P. et al. Ensembl 2013. Nucleic Acids Res. 41, D48–D55 (2013).
Google Scholar
Meyer, L. R. et al. The UCSC Genome Browser database: extensions and updates 2013. Nucleic Acids Res. 41, D64–D69 (2013).
Google Scholar
Katz, Y., Wang, E. T., Airoldi, E. M. & Burge, C. B. Analysis and design of RNA sequencing experiments for identifying isoform regulation. Nat. Methods 7, 1009–1015 (2010).
Google Scholar
Li, B. & Dewey, C. N. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinf. 12, 323 (2011).
Google Scholar
Trapnell, C., Pachter, L. & Salzberg, S. L. TopHat: discovering splice junctions with RNA-Seq. Bioinformatics 25, 1105–1111 (2009).
Google Scholar
Lavallée, V.-P. et al. The transcriptomic landscape and directed chemical interrogation of MLL-rearranged acute myeloid leukemias. Nat. Genet. https://doi.org/10.1038/ng.3371 (2015).
Taylor, J. et al. Single-cell genomics reveals the genetic and molecular bases for escape from mutational epistasis in myeloid neoplasms. Blood 136, 1477–1486 (2020).
Google Scholar
